Trump may be mystery patient in odd case of 79yo getting experimental obesity drug
Speculation is rising over whether Donald Trump is the 79-year-old patient who received exclusive access to an experimental weight loss drug.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
Reports indicate that Eli Lilly allowed one-time access to a next-generation obesity drug, Retatrutide, for a 79-year-old patient. This has led to questions regarding whether Donald Trump is the individual in question.
Coverage from Ars Technica, Mother Jones, and The Daily Beast highlights the mystery surrounding the patient's identity. Meanwhile, Forbes reports that the White House has denied that Trump was given the exclusive medication.
Future developments depend on the White House's response to inquiries about the patient's identity and any further updates regarding Lilly's access protocols for the drug.
Synthesized by Archynetys from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 2h ago.
Quick answers
What drug is at the center of this trend?
The experimental next-generation obesity drug Retatrutide.
How has the White House responded to these claims?
According to Forbes, the White House denies that Trump was given the exclusive weight loss drug.
Who provided the drug access?
Seeking Alpha reports that Lilly allowed the one-time access.
Coverage (7)
- Did Donald Trump Use His Office to Get a Powerful New Weight Loss Drug? Sure Looks Like It! Slate Magazine · 5h ago
- White House Cornered on Identity of Patient, 79, Given Special Weight Loss Drug The Daily Beast · 5h ago
- White House Denies Trump Was Given Exclusive Weight Loss Drug Forbes · 5h ago
- Did Trump Get Special Access to Retatrutide? Mother Jones · 5h ago
- Remember That Time Trump Said He “Probably Should” Take Ozempic? The New Republic · 5h ago
- Lilly allows one-time access to next-gen obesity drug (update) Seeking Alpha · 5h ago
- Trump may be mystery patient in odd case of 79yo getting experimental obesity drug Ars Technica · 5h ago
Topics
Related trends
Trump Gets Negative Reviews Internationally as Fewer Say U.S. Is a Reliable Partner
A new Pew Research Center global survey indicates a decline in international trust toward the U.S. and negative views of Donald Trump.
Regime Change: The Big Beautiful Beach Read
A new book examining Donald Trump's second term and his efforts to test executive power is generating significant media attention.
Starmer announces he'll resign as UK prime minister as Burnham confirms bid to succeed him
UK Prime Minister Keir Starmer's resignation triggers a leadership contest and economic uncertainty
Colombian presidential election live: Trump-endorsed De La Espriella leads vote count ahead of leftist Cepeda
A Trump-endorsed candidate appears to have won Colombia's presidential election, sparking global interest.
Trump says UK Prime Minister Keir Starmer to resign: 'Failed'
British Prime Minister Keir Starmer has resigned following a period of intense pressure and a party mutiny.
Josh Hokit responds to ‘fat cow pig’ Daniel Cormier’s criticism of his antics
UFC fighter Josh Hokit's controversial remarks at the White House spark widespread backlash and responses from fellow fighters and UFC president Dana White.